Diagnostic Performance and Usability of the Genedrive ® HCV ID Kit in Two Decentralized Settings in Cameroon and Georgia

• Published in: Diagnostics (Basel) Vol. 11; no. 5; p. 746
• Main Authors: Lamoury, Francois M J, Njouom, Richard, Amougou-Atsama, Marie, Yiagnigni Mfopou, Euloge, Berishvili, Nino, Sologashvili, Manana, Fajardo, Emmanuel, Malobela, Agnes, Macé, Aurélien, Chirehwa, Maxwell, Alkhazashvili, Maia, Ivanova Reipold, Elena
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 22.04.2021; MDPI
• Subjects: Chronic illnesses; diagnostics; Disease control; Genedrive; Genotype & phenotype; HCV RNA; Hepatitis C; Infections; Laboratories; Plasma; point-of-care; Population; Sample size; Usability; Cameroon; HCV RNA; diagnostics; Genedrive; Hepatitis C; point-of-care

Point-of-care diagnostics have the potential to increase diagnosis and linkage to care and help reach the WHO targets to eliminate hepatitis C virus (HCV) by 2030. Here, we evaluated the diagnostic accuracy of Genedrive HCV ID assay for the qualitative detection of HCV RNA in decentralized settings...